{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T06:11:25Z","timestamp":1696918285293},"reference-count":17,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2009,5,26]],"date-time":"2009-05-26T00:00:00Z","timestamp":1243296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2009,8]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The aim of this prospective study was to analyze the incidence of serious infections and changes in immunological markers after liver transplantation (LT) in a cohort of patients with hepatitis C virus (HCV). This study included 34 patients who had LT, 20 patients with HCV etiology (HCV group), and 14 patients with alcoholic etiology (non\u2010HCV group). Patients with HCV were more likely to have severe infections (80%) in comparison with patients in the non\u2010HCV group (42%) (<jats:italic>P<\/jats:italic>=0.05). The HCV group had a 3\u2010fold greater likelihood of early severe bacterial infections than the non\u2010HCV group. At 1 week post LT, the HCV group showed higher values of CD19+ B cells\/\u03bcL than the non\u2010HCV group (<jats:italic>P<\/jats:italic>&lt;0.05). At weeks 4 and 12 post LT, the HCV group had lower values of CD19+ B cells\/\u03bcL (<jats:italic>P<\/jats:italic>&lt;0.05). Our data suggest that HCV recurrence after LT was associated with a high incidence of early severe infections and immunological alterations, which may be related to this increased risk.<\/jats:p>","DOI":"10.1111\/j.1399-3062.2009.00408.x","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T02:30:44Z","timestamp":1243391444000},"page":"367-372","source":"Crossref","is-referenced-by-count":2,"title":["High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation"],"prefix":"10.1111","volume":"11","author":[{"given":"D.","family":"Micheloud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ba\u00f1ares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.J.","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fern\u00e1ndez\u2010Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Carbone Campoverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Resino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,8,4]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199806113382407"},{"key":"e_1_2_6_3_2","first-page":"125","article-title":"The direct and indirect effects of infection in liver transplantation","volume":"22","author":"Rubin RH.","year":"2002","journal-title":"pathogenesis, impact, and clinical management"},{"issue":"5","key":"e_1_2_6_4_2","first-page":"697","article-title":"Hypogammaglobulinemia in liver transplant recipients","volume":"81","author":"Doron S","year":"2006","journal-title":"incidence, timing, risk factors, and outcomes"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31773"},{"issue":"1","key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.1840200104","article-title":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group","volume":"20","year":"1994","journal-title":"Hepatology"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2885.1998.00143.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-6553(88)90053-3"},{"issue":"1","key":"e_1_2_6_9_2","first-page":"54","article-title":"Predicting bacteremia and bacteremic mortality in liver transplant recipients","volume":"6","author":"Singh N","year":"2000","journal-title":"Liver Transpl"},{"issue":"7","key":"e_1_2_6_10_2","first-page":"844","article-title":"Bacteremias in liver transplant recipients","volume":"10","author":"Singh N","year":"2004","journal-title":"shift toward gram-negative bacteria as predominant pathogens"},{"issue":"4","key":"e_1_2_6_11_2","first-page":"710","article-title":"Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications","volume":"44","author":"Llado L","year":"2006","journal-title":"results from a prospective multicenter randomized study"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00452-3"},{"issue":"1","key":"e_1_2_6_13_2","first-page":"47","article-title":"Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes","volume":"12","author":"Wu CG","year":"2006","journal-title":"Mol Med"},{"issue":"2","key":"e_1_2_6_14_2","first-page":"152","article-title":"Chronic infections with hepatotropic viruses","volume":"27","author":"Rehermann B.","year":"2007","journal-title":"mechanisms of impairment of cellular immune responses"},{"issue":"54","key":"e_1_2_6_15_2","first-page":"2121","article-title":"Serum immunoglobulins (IgG, IgA, IgM) in chronic hepatitis C. A comparison with non\u2010cirrhotic alcoholic liver disease","volume":"50","author":"Gonzalez\u2010Quintela A","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0966-3274(02)00084-9"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107455"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01729.x"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-3062.2009.00408.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-3062.2009.00408.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:53:10Z","timestamp":1696870390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-3062.2009.00408.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["10.1111\/j.1399-3062.2009.00408.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-3062.2009.00408.x","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}